Do-Fluoride New Materials（002407）株式概要堂弗化新材料有限公司は、無機フッ化物、電子化学品、リチウムイオン電池および関連材料の開発、製造、販売を中国国内および海外で行っている。 詳細002407 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長4/6過去の実績2/6財務の健全性5/6配当金3/6報酬収益は年間22.63%増加すると予測されています 今年は黒字化を達成 リスク分析CN市場と比較した過去 3 か月間の株価の変動0.47%の配当はフリーキャッシュフローで十分にカバーされていない すべてのリスクチェックを見る002407 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCN¥Current PriceCN¥42.7048.3% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-454m28b2016201920222025202620282031Revenue CN¥28.1bEarnings CN¥1.4bAdvancedSet Fair ValueView all narrativesDo-Fluoride New Materials Co., Ltd. 競合他社Hengyi PetrochemicalSymbol: SZSE:000703Market cap: CN¥47.6bHuafon ChemicalLtdSymbol: SZSE:002064Market cap: CN¥51.6bFSPG Hi-TechSymbol: SZSE:000973Market cap: CN¥37.6bLB GroupSymbol: SZSE:002601Market cap: CN¥37.6b価格と性能株価の高値、安値、推移の概要Do-Fluoride New Materials過去の株価現在の株価CN¥42.7052週高値CN¥43.8952週安値CN¥11.13ベータ1.051ヶ月の変化42.14%3ヶ月変化40.09%1年変化268.42%3年間の変化110.66%5年間の変化118.57%IPOからの変化97.69%最新ニュースBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Pingjiao Yu was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 16Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan Chinaお知らせ • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026お知らせ • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 16, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 16, 2026お知らせ • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 23, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 23, 2025お知らせ • Jul 02Do-Fluoride New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025最新情報をもっと見るRecent updatesBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Pingjiao Yu was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 16Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan Chinaお知らせ • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026お知らせ • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 16, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 16, 2026お知らせ • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 23, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 23, 2025お知らせ • Jul 02Do-Fluoride New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025お知らせ • Apr 25Do-Fluoride New Materials Co., Ltd. Proposes Final Cash Distribution for 2024Do-Fluoride New Materials Co., Ltd. announced on 24 April 2025 the final profit distribution proposal for 2024 as follows: Cash dividend/10 shares (tax included): CNY 2.00000000.お知らせ • Apr 24Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan Chinaお知らせ • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025お知らせ • Jan 23Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million.Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million on January 21, 2025. A cash consideration of CNY 28.46 million will be paid by Do-Fluoride New Materials Co., Ltd. As part of consideration, CNY 28.46 million is paid towards common equity of Henan Yifeng Electronic New Materials Co., Ltd. The transaction will be financed through equity investment of CNY 28.46 million. As of October 31, 2024 Henan Yifeng Electronic New Materials Co., Ltd. reported total assets of CNY 65 million and net assets of CNY 40 million. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board.お知らせ • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025Reported Earnings • Nov 01Third quarter 2024 earnings released: CN¥0.033 loss per share (vs CN¥0.14 profit in 3Q 2023)Third quarter 2024 results: CN¥0.033 loss per share (down from CN¥0.14 profit in 3Q 2023). Revenue: CN¥2.27b (down 36% from 3Q 2023). Net loss: CN¥45.4m (down 123% from profit in 3Q 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.42, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.58 per share.お知らせ • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥11.38, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.26 per share.Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.022 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.022 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥2.48b (down 11% from 2Q 2023). Net income: CN¥30.8m (down 81% from 2Q 2023). Profit margin: 1.2% (down from 5.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has fallen by 35% per year, which means it is performing significantly worse than earnings.New Risk • Aug 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 28% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 112% Paying a dividend despite having no free cash flows. High level of non-cash earnings (28% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (2.8% net profit margin). Shareholders have been diluted in the past year (11% increase in shares outstanding).Buy Or Sell Opportunity • Aug 27Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 29% to CN¥9.48. The fair value is estimated to be CN¥12.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 66% in 2 years. Earnings are forecast to grow by 217% in the next 2 years.お知らせ • Jun 29Do-Fluoride New Materials Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024Valuation Update With 7 Day Price Move • Apr 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥13.39, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 7.8% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.60 per share.お知らせ • Mar 30Do-Fluoride New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024お知らせ • Mar 29Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan ChinaReported Earnings • Mar 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥509.8m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Reported Earnings • Feb 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥508.6m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥10.50, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 33% over the past three years.お知らせ • Dec 30Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.31 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.31 in 3Q 2022). Revenue: CN¥3.52b (up 7.7% from 3Q 2022). Net income: CN¥194.4m (down 41% from 3Q 2022). Profit margin: 5.5% (down from 10.0% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.New Risk • Aug 31New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (7.0% net profit margin). Shareholders have been diluted in the past year (11% increase in shares outstanding).Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.63 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.63 in 2Q 2022). Revenue: CN¥2.79b (down 17% from 2Q 2022). Net income: CN¥158.5m (down 76% from 2Q 2022). Profit margin: 5.7% (down from 20% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 23Full year 2022 earnings released: EPS: CN¥2.54 (vs CN¥1.73 in FY 2021)Full year 2022 results: EPS: CN¥2.54 (up from CN¥1.73 in FY 2021). Revenue: CN¥12.4b (up 58% from FY 2021). Net income: CN¥1.95b (up 55% from FY 2021). Profit margin: 16% (in line with FY 2021). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth.Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Independent Director Chunyan Li was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Valuation Update With 7 Day Price Move • Nov 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥38.22, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 230% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.93 per share.Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.57 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.43 (down from CN¥0.57 in 3Q 2021). Revenue: CN¥3.27b (up 36% from 3Q 2021). Net income: CN¥326.6m (down 24% from 3Q 2021). Profit margin: 10.0% (down from 18% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: CN¥0.88 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.88 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥3.37b (up 102% from 2Q 2021). Net income: CN¥670.6m (up 212% from 2Q 2021). Profit margin: 20% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 33%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥47.51, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 247% over the past three years.Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥39.15, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 242% over the past three years.Buying Opportunity • Apr 29Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 26%. The fair value is estimated to be CN¥38.13, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 108%. Revenue is forecast to grow by 63% in 2 years. Earnings is forecast to grow by 3.5% in the next 2 years.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥42.16, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥38.76 per share.Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥1.73 (up from CN¥0.07 in FY 2020). Revenue: CN¥7.81b (up 84% from FY 2020). Net income: CN¥1.26b (up CN¥1.21b from FY 2020). Profit margin: 16% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 30%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.Reported Earnings • Oct 16Third quarter 2021 earnings released: EPS CN¥0.57 (vs CN¥0.003 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.40b (up 111% from 3Q 2020). Net income: CN¥429.4m (up CN¥431.5m from 3Q 2020). Profit margin: 18% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 27Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.021 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.67b (up 81% from 2Q 2020). Net income: CN¥214.7m (up CN¥200.2m from 2Q 2020). Profit margin: 13% (up from 1.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 63% per year, which means it is well ahead of earnings.Reported Earnings • Apr 26Full year 2020 earnings released: EPS CN¥0.071 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 08Full year 2020 earnings released: EPS CN¥0.07 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Jan 18New 90-day high: CN¥21.23The company is up 33% from its price of CN¥15.95 on 21 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Dec 25New 90-day high: CN¥20.31The company is up 66% from its price of CN¥12.24 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Dec 09New 90-day high: CN¥17.26The company is up 57% from its price of CN¥10.98 on 10 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Nov 10New 90-day high: CN¥16.90The company is up 49% from its price of CN¥11.37 on 12 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.89 per share.Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥504.7m, with losses widening by CN¥499.6m from the prior year. Total revenue was CN¥3.74b over the last 12 months, down 13% from the prior year.Is New 90 Day High Low • Oct 10New 90-day high: CN¥13.80The company is up 16% from its price of CN¥11.92 on 10 July 2020. The Chinese market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.44 per share.Is New 90 Day High Low • Sep 18New 90-day high: CN¥13.32The company is up 21% from its price of CN¥11.00 on 19 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.34 per share.株主還元002407CN ChemicalsCN 市場7D17.1%-1.3%-0.04%1Y268.4%61.9%34.9%株主還元を見る業界別リターン: 002407過去 1 年間で61.9 % の収益を上げたCN Chemicals業界を上回りました。リターン対市場: 002407過去 1 年間で34.9 % の収益を上げたCN市場を上回りました。価格変動Is 002407's price volatile compared to industry and market?002407 volatility002407 Average Weekly Movement8.6%Chemicals Industry Average Movement6.8%Market Average Movement6.4%10% most volatile stocks in CN Market10.1%10% least volatile stocks in CN Market4.2%安定した株価: 002407の株価は、 CN市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 002407の weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてCNの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19998,040Yun Feng Liwww.dfdchem.com堂弗化新材料有限公司は、無機フッ化物、電子化学品、リチウムイオン電池および関連材料の開発、製造、販売を中国国内および海外で行っている。同社は氷晶石、無水フッ化アルミニウム、フッ化ナトリウム・フッ化ケイ酸塩、フッ化ケイ酸カリウム、ホワイトカーボンブラック、無水フッ化水素を提供している；六フッ化リン酸リチウムおよび二フッ化リン酸リチウム、ビスフルオロスルホニルイミドリチウム、六フッ化リン酸ナトリウム、四フッ化ホウ酸リチウム、二フッ化シュウ酸ホウ酸リチウム、フッ化水素酸、硝酸、アンモニア、フッ化アンモニウム。また、新エネルギー用リチウムイオン電池のカスタマイズサービスも提供している。同社は以前、ドフッ化ケミカルズ株式会社として知られていた。Ltd.は1999年に設立され、中華人民共和国の焦作を拠点としている。もっと見るDo-Fluoride New Materials Co., Ltd. 基礎のまとめDo-Fluoride New Materials の収益と売上を時価総額と比較するとどうか。002407 基礎統計学時価総額CN¥49.36b収益（TTM）CN¥523.58m売上高(TTM)CN¥10.55b94.3xPER（株価収益率4.7xP/Sレシオ002407 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計002407 損益計算書（TTM）収益CN¥10.55b売上原価CN¥8.65b売上総利益CN¥1.90bその他の費用CN¥1.38b収益CN¥523.58m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.45グロス・マージン18.03%純利益率4.96%有利子負債／自己資本比率83.1%002407 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.5%現在の配当利回り46%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 07:36終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Do-Fluoride New Materials Co., Ltd. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Zhe WangCitic Securities Co., Ltd.Dongying WuCitigroup IncJack LuMorgan Stanley1 その他のアナリストを表示
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Pingjiao Yu was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 16Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
お知らせ • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
お知らせ • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 16, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 16, 2026
お知らせ • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 23, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 23, 2025
お知らせ • Jul 02Do-Fluoride New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Pingjiao Yu was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 16Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
お知らせ • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
お知らせ • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 16, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 16, 2026
お知らせ • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 23, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 23, 2025
お知らせ • Jul 02Do-Fluoride New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025
お知らせ • Apr 25Do-Fluoride New Materials Co., Ltd. Proposes Final Cash Distribution for 2024Do-Fluoride New Materials Co., Ltd. announced on 24 April 2025 the final profit distribution proposal for 2024 as follows: Cash dividend/10 shares (tax included): CNY 2.00000000.
お知らせ • Apr 24Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
お知らせ • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025
お知らせ • Jan 23Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million.Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million on January 21, 2025. A cash consideration of CNY 28.46 million will be paid by Do-Fluoride New Materials Co., Ltd. As part of consideration, CNY 28.46 million is paid towards common equity of Henan Yifeng Electronic New Materials Co., Ltd. The transaction will be financed through equity investment of CNY 28.46 million. As of October 31, 2024 Henan Yifeng Electronic New Materials Co., Ltd. reported total assets of CNY 65 million and net assets of CNY 40 million. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board.
お知らせ • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025
Reported Earnings • Nov 01Third quarter 2024 earnings released: CN¥0.033 loss per share (vs CN¥0.14 profit in 3Q 2023)Third quarter 2024 results: CN¥0.033 loss per share (down from CN¥0.14 profit in 3Q 2023). Revenue: CN¥2.27b (down 36% from 3Q 2023). Net loss: CN¥45.4m (down 123% from profit in 3Q 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.42, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.58 per share.
お知らせ • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥11.38, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.26 per share.
Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.022 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.022 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥2.48b (down 11% from 2Q 2023). Net income: CN¥30.8m (down 81% from 2Q 2023). Profit margin: 1.2% (down from 5.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has fallen by 35% per year, which means it is performing significantly worse than earnings.
New Risk • Aug 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 28% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 112% Paying a dividend despite having no free cash flows. High level of non-cash earnings (28% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (2.8% net profit margin). Shareholders have been diluted in the past year (11% increase in shares outstanding).
Buy Or Sell Opportunity • Aug 27Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 29% to CN¥9.48. The fair value is estimated to be CN¥12.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 66% in 2 years. Earnings are forecast to grow by 217% in the next 2 years.
お知らせ • Jun 29Do-Fluoride New Materials Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024
Valuation Update With 7 Day Price Move • Apr 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥13.39, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 7.8% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.60 per share.
お知らせ • Mar 30Do-Fluoride New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
お知らせ • Mar 29Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
Reported Earnings • Mar 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥509.8m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Reported Earnings • Feb 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥508.6m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥10.50, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 33% over the past three years.
お知らせ • Dec 30Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.31 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.31 in 3Q 2022). Revenue: CN¥3.52b (up 7.7% from 3Q 2022). Net income: CN¥194.4m (down 41% from 3Q 2022). Profit margin: 5.5% (down from 10.0% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
New Risk • Aug 31New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (7.0% net profit margin). Shareholders have been diluted in the past year (11% increase in shares outstanding).
Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.63 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.63 in 2Q 2022). Revenue: CN¥2.79b (down 17% from 2Q 2022). Net income: CN¥158.5m (down 76% from 2Q 2022). Profit margin: 5.7% (down from 20% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 23Full year 2022 earnings released: EPS: CN¥2.54 (vs CN¥1.73 in FY 2021)Full year 2022 results: EPS: CN¥2.54 (up from CN¥1.73 in FY 2021). Revenue: CN¥12.4b (up 58% from FY 2021). Net income: CN¥1.95b (up 55% from FY 2021). Profit margin: 16% (in line with FY 2021). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth.
Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Independent Director Chunyan Li was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Nov 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥38.22, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 230% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.93 per share.
Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.57 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.43 (down from CN¥0.57 in 3Q 2021). Revenue: CN¥3.27b (up 36% from 3Q 2021). Net income: CN¥326.6m (down 24% from 3Q 2021). Profit margin: 10.0% (down from 18% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: CN¥0.88 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.88 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥3.37b (up 102% from 2Q 2021). Net income: CN¥670.6m (up 212% from 2Q 2021). Profit margin: 20% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 33%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥47.51, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 247% over the past three years.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥39.15, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 242% over the past three years.
Buying Opportunity • Apr 29Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 26%. The fair value is estimated to be CN¥38.13, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 108%. Revenue is forecast to grow by 63% in 2 years. Earnings is forecast to grow by 3.5% in the next 2 years.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥42.16, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥38.76 per share.
Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥1.73 (up from CN¥0.07 in FY 2020). Revenue: CN¥7.81b (up 84% from FY 2020). Net income: CN¥1.26b (up CN¥1.21b from FY 2020). Profit margin: 16% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 30%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Oct 16Third quarter 2021 earnings released: EPS CN¥0.57 (vs CN¥0.003 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.40b (up 111% from 3Q 2020). Net income: CN¥429.4m (up CN¥431.5m from 3Q 2020). Profit margin: 18% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 27Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.021 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.67b (up 81% from 2Q 2020). Net income: CN¥214.7m (up CN¥200.2m from 2Q 2020). Profit margin: 13% (up from 1.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 63% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 26Full year 2020 earnings released: EPS CN¥0.071 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 08Full year 2020 earnings released: EPS CN¥0.07 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Jan 18New 90-day high: CN¥21.23The company is up 33% from its price of CN¥15.95 on 21 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Dec 25New 90-day high: CN¥20.31The company is up 66% from its price of CN¥12.24 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Dec 09New 90-day high: CN¥17.26The company is up 57% from its price of CN¥10.98 on 10 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Nov 10New 90-day high: CN¥16.90The company is up 49% from its price of CN¥11.37 on 12 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.89 per share.
Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥504.7m, with losses widening by CN¥499.6m from the prior year. Total revenue was CN¥3.74b over the last 12 months, down 13% from the prior year.
Is New 90 Day High Low • Oct 10New 90-day high: CN¥13.80The company is up 16% from its price of CN¥11.92 on 10 July 2020. The Chinese market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.44 per share.
Is New 90 Day High Low • Sep 18New 90-day high: CN¥13.32The company is up 21% from its price of CN¥11.00 on 19 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.34 per share.
